Безопасен ли troloxoyl sh-pentapeptide-12 sp при беременности?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety opinion located, and no peer-reviewed reproductive toxicity or human pregnancy data found for Troloxoyl SH‑pentapeptide‑12. As a peptide conjugate with no evidence of systemic reproductive toxicity, default scoring is 0 for hazard and mechanism; expected dermal absorption from topical cosmetic use is negligible (peptides are large/polar), so exposure scored 0. Sources checked: ECHA Annex VI (no entry), SCCS/CIR (no assessment), PubMed (no relevant reproductive studies), CosIng/PubChem (ingredient listing only).
Related ingredients
Frequently asked questions
- Безопасен ли troloxoyl sh-pentapeptide-12 sp при беременности?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety opinion located, and no peer-reviewed reproductive toxicity or human pregnancy data found for Troloxoyl SH‑pentapeptide‑12. As a peptide conjugate with no evidence of systemic reproductive toxicity, default scoring is 0 for hazard and mechanism; expected dermal absorption from topical cosmetic use is negligible (peptides are large/polar), so exposure scored 0. Sources checked: ECHA Annex VI (no entry), SCCS/CIR (no assessment), PubMed (no relevant reproductive studies), CosIng/PubChem (ingredient listing only).
- Безопасен ли troloxoyl sh-pentapeptide-12 sp при грудном вскармливании?
- Same rationale as pregnancy: no harmonised classifications or authoritative safety assessments indicating reproductive or lactation risk; no data demonstrating mammary transfer or effects on lactation. Topical peptide conjugates are expected to have negligible systemic availability under normal cosmetic use.
- Безопасен ли troloxoyl sh-pentapeptide-12 sp для кожи малыша?
- No infant-specific data were identified. Peptide conjugates are generally large molecules with low skin penetration, so exposure for babies (0–3 yr) is assessed as negligible in absence of absorption data. Per instruction, baby exposure was not increased because adult exposure is considered negligible and no data indicate measurable absorption.
- Как VeriMom оценивает troloxoyl sh-pentapeptide-12 sp?
- VeriMom оценивает troloxoyl sh-pentapeptide-12 sp в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы troloxoyl sh-pentapeptide-12 sp при беременности?
- См. наш список безопасных альтернатив troloxoyl sh-pentapeptide-12 sp с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.